Naviscan Receives Regulatory Approval to Export to Colombia

SAN DIEGO,  March 30 /PRNewswire/ -- Naviscan received approval from the Colombian Ministry of Health for the commercial introduction of its Positron Emission Mammography (PEM) scanner into Colombia.  Naviscan manufactures the only commercially available PEM imaging scanner and PEM-guided biopsy system. The scanner uses PET technology to produce tomographic images that allow physicians to visualize breast tumors down to 2 mm, the width of a grain of rice.  The scanner is the size of a mammography unit and uses gentle breast immobilization, allowing for greater patient comfort, as well as reducing motion artifact and improving image resolution.

Partnering with Nuclear Medicine Distributors LLC (NMD), Naviscan has shipped its first PEM scanner to Colombia this month, which will be installed at University Hospital of the Fundacion Santa Fe de Bogota, a prestigious Latin American healthcare institution.   Additional units are scheduled to be shipped during 2010.   Nuclear Medicine Distributors, Naviscan's distribution partner in Colombia, Peru, Venezuela and Dominican Republic, is leading the introduction of PEM technology into South America.

"With the approval by the Colombian regulatory officials, Naviscan's globalization strategy continues its momentum," said Paul Mirabella, Chairman and CEO, Naviscan, Inc.  "Coupled with our sales in Korea, Venezuela and Japan, we are excited by the growth we are experiencing in international markets."

"The arrival of the PEM scanner to our institution reaffirms our commitment to the Colombian people of incorporating the most advanced technology available that provides important contributions to the health of individuals, in this case for women with breast cancer," stated Dr. Roberto Esguerra, Chairman of Fundacion Santa Fe de Bogota.

About Naviscan, Inc.

Naviscan, Inc., founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging, guide radiological and surgical procedures and advance new clinical therapies.   The Naviscan PET scanner is currently installed and available in breast and imaging centers throughout the U.S. as well as utilized in clinical research studies, funded in part by the National Institutes of Health.  The Company is headquartered in San Diego, California and is the first company to obtain FDA clearance of a high-resolution PET scanner designed to image small body parts.   For more information, call 1.858.587.3641 or visit www.naviscan.com.

SOURCE Naviscan, Inc.